1. Home
  2. NVAX vs HSAI Comparison

NVAX vs HSAI Comparison

Compare NVAX & HSAI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Novavax Inc.

NVAX

Novavax Inc.

N/A

Current Price

$12.78

Market Cap

2.1B

Sector

Health Care

ML Signal

N/A

Logo Hesai Group each ADS represents one Class B ordinary share

HSAI

Hesai Group each ADS represents one Class B ordinary share

N/A

Current Price

$16.00

Market Cap

2.4B

Sector

N/A

ML Signal

N/A

Company Overview

Basic Information
Metric
NVAX
HSAI
Founded
1987
2014
Country
United States
China
Employees
N/A
N/A
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.1B
2.4B
IPO Year
1996
2021

Fundamental Metrics

Financial Performance
Metric
NVAX
HSAI
Price
$12.78
$16.00
Analyst Decision
Buy
Strong Buy
Analyst Count
9
19
Target Price
$14.00
★ $28.49
AVG Volume (30 Days)
★ 6.6M
885.1K
Earning Date
11-05-2026
11-10-2026
Dividend Yield
N/A
N/A
EPS Growth
★ 309.76
N/A
EPS
N/A
★ N/A
Revenue
★ $1,123,479,000.00
N/A
Revenue This Year
N/A
$41.85
Revenue Next Year
N/A
$41.74
P/E Ratio
★ N/A
$61.18
Revenue Growth
★ 64.69
N/A
52 Week Low
$6.20
$14.29
52 Week High
$13.39
$29.35

Technical Indicators

Market Signals
Indicator
NVAX
HSAI
Relative Strength Index (RSI) 68.95 46.02
Support Level $7.64 $15.81
Resistance Level N/A $19.29
Average True Range (ATR) 0.97 0.40
MACD 0.11 0.01
Stochastic Oscillator 85.02 34.31

Price Performance

Historical Comparison
NVAX
HSAI

About NVAX Novavax Inc.

Novavax Inc is a biotechnology company that develops vaccines. The company works in the clinical stage of development with a focus on delivering novel products that prevent a broad range of diseases. It works together with its wholly owned Swedish subsidiary to produce vaccine candidates to respond to both known and emerging disease threats. The company believes its vaccine technology has the potential to be applied broadly to a wide variety of human infectious diseases. The company manages its business as one operating segment, an in-house early-stage R&D business to build a pipeline of high-value assets using its technology along with seeking to enter into partnerships to drive value creation for its assets.

About HSAI Hesai Group each ADS represents one Class B ordinary share

Hesai Group is engaged in the development, manufacture, and sales of three-dimensional light detection and ranging solutions, or LiDAR. Its LiDAR products enable a broad spectrum of applications across passenger or commercial vehicles with enhanced driver assistance systems, or ADAS, autonomous vehicle fleets providing passenger and freight mobility services, or Autonomous Mobility, and other applications such as last-mile delivery robots, street sweeping robots, and logistics robots in restricted areas, or Robotics. Geographically, the company operates in North America, Mainland China, Europe, and Other regions.

Share on Social Networks: